AVID BIOSERVICES, INC.: depreciation, depletion and amortization
Depreciation, depletion and amortization for AVID BIOSERVICES, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AVID BIOSERVICES, INC. financial histories
What this measure means
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
Exact concept: us-gaap:DepreciationDepletionAndAmortization. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-05-01 to 2024-04-30. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-05-01 | 2024-04-30 | 11,109,000 | USD | 2024-07-02 | 10-K · 0001683168-24-004610 |
| 2022-05-01 | 2023-04-30 | 7,210,000 | USD | 2024-07-02 | 10-K · 0001683168-24-004610 |
| 2021-05-01 | 2022-04-30 | 4,480,000 | USD | 2024-07-02 | 10-K · 0001683168-24-004610 |
| 2020-05-01 | 2021-04-30 | 3,453,000 | USD | 2024-04-24 | 10-K/A · 0001683168-24-002656 |
| 2019-05-01 | 2020-04-30 | 3,091,000 | USD | 2022-06-29 | 10-K · 0001683168-22-004704 |
| 2018-05-01 | 2019-04-30 | 2,746,000 | USD | 2021-06-29 | 10-K · 0001683168-21-002764 |
| 2017-05-01 | 2018-04-30 | 2,562,000 | USD | 2020-06-30 | 10-K · 0001683168-20-002138 |
| 2016-05-01 | 2017-04-30 | 2,463,000 | USD | 2019-06-27 | 10-K · 0001683168-19-002038 |
| 2015-05-01 | 2016-04-30 | 1,535,000 | USD | 2018-07-16 | 10-K · 0001683168-18-001961 |
| 2014-05-01 | 2015-04-30 | 1,041,000 | USD | 2017-07-14 | 10-K · 0001683168-17-001772 |
| 2013-05-01 | 2014-04-30 | 986,000 | USD | 2016-07-14 | 10-K · 0001019687-16-006937 |
| 2012-05-01 | 2013-04-30 | 1,087,000 | USD | 2015-07-14 | 10-K · 0001019687-15-002732 |
| 2011-05-01 | 2012-04-30 | 908,000 | USD | 2014-07-14 | 10-K · 0001354488-14-003653 |
| 2010-05-01 | 2011-04-30 | 652,000 | USD | 2013-07-11 | 10-K · 0001019687-13-002616 |
| 2009-05-01 | 2010-04-30 | 447,000 | USD | 2012-07-16 | 10-K · 0001019687-12-002424 |
Related financial histories
- AVID BIOSERVICES, INC.: total assets
- AVID BIOSERVICES, INC.: total liabilities
- AVID BIOSERVICES, INC.: stockholders equity
- AVID BIOSERVICES, INC.: cash and cash equivalents
- AVID BIOSERVICES, INC.: net income or loss
- AVID BIOSERVICES, INC.: operating cash flow
- AVID BIOSERVICES, INC.: capital expenditure payments
- AVID BIOSERVICES, INC.: revenue
- AVID BIOSERVICES, INC.: contract revenue excluding tax
- AVID BIOSERVICES, INC.: financing cash flow
- AVID BIOSERVICES, INC.: investing cash flow
- AVID BIOSERVICES, INC.: retained earnings or deficit
- AVID BIOSERVICES, INC.: basic weighted-average shares
- AVID BIOSERVICES, INC.: diluted weighted-average shares
- AVID BIOSERVICES, INC.: basic earnings per share
- AVID BIOSERVICES, INC.: diluted earnings per share
- AVID BIOSERVICES, INC.: income tax expense or benefit
- AVID BIOSERVICES, INC.: net property, plant and equipment
- AVID BIOSERVICES, INC.: share-based compensation expense
- AVID BIOSERVICES, INC.: operating income or loss
- AVID BIOSERVICES, INC.: current assets
- AVID BIOSERVICES, INC.: interest expense
- AVID BIOSERVICES, INC.: current liabilities
- AVID BIOSERVICES, INC.: current accounts payable
- AVID BIOSERVICES, INC.: net current accounts receivable
- AVID BIOSERVICES, INC.: operating expenses
- AVID BIOSERVICES, INC.: net inventory
- AVID BIOSERVICES, INC.: gross profit
- AVID BIOSERVICES, INC.: cost of revenue
- AVID BIOSERVICES, INC.: selling, general and administrative expense
- AVID BIOSERVICES, INC.: research and development expense
- AVID BIOSERVICES, INC.: common shares outstanding
- AVID BIOSERVICES, INC.: cash including restricted cash
- AVID BIOSERVICES, INC.: additional paid-in capital
- AVID BIOSERVICES, INC.: operating lease right-of-use asset
- AVID BIOSERVICES, INC.: long-term debt
- AVID BIOSERVICES, INC.: gross property, plant and equipment
- AVID BIOSERVICES, INC.: accumulated depreciation on property, plant and equipment
- AVID BIOSERVICES, INC.: other noncurrent assets
- AVID BIOSERVICES, INC.: other noncurrent liabilities
- AVID BIOSERVICES, INC.: prepaid expenses and other current assets
- AVID BIOSERVICES, INC.: current contract liabilities
- AVID BIOSERVICES, INC.: net deferred tax assets
- AVID BIOSERVICES, INC.: pre-tax income or loss from continuing operations
- AVID BIOSERVICES, INC.: comprehensive income or loss
- AVID BIOSERVICES, INC.: net income available to common stockholders
- AVID BIOSERVICES, INC.: other nonoperating income or expense
- AVID BIOSERVICES, INC.: current income tax expense or benefit
- AVID BIOSERVICES, INC.: deferred income tax expense or benefit
- AVID BIOSERVICES, INC.: interest paid, net
- AVID BIOSERVICES, INC.: income taxes paid, net
- AVID BIOSERVICES, INC.: proceeds from issuing common stock
- AVID BIOSERVICES, INC.: operating lease payments
- AVID BIOSERVICES, INC.: change in accounts receivable
- AVID BIOSERVICES, INC.: change in inventories
- AVID BIOSERVICES, INC.: change in accounts payable
Inspect the source
- Entity
- AVID BIOSERVICES, INC. / CIK 0000704562
- Captured
- 2026-09-21T17:16:37.815Z
- SEC response SHA-256
896f97a2d8184ef2d2a6950187d78ffa111f7fc522d68b0bca9ac1f226907230
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000704562.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))